|
1
|
Ramakrishnan R and Gabrilovich DI: Novel
mechanism of synergistic effects of conventional chemotherapy and
immune therapy of cancer. Cancer Immunol Immunother. 62:405–410.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Lee HE, Chae SW, Lee YJ, Kim MA, Lee HS,
Lee BL and Kim WH: Prognostic implications of type and density of
tumour-infiltrating lymphocytes in gastric cancer. Br J Cancer.
99:1704–1711. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Rosser EC and Mauri C: Regulatory B cells:
Origin, phenotype, and function. Immunity. 42:607–612. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Schmidt M, Böhm D, von Törne C, Steiner E,
Puhl A, Pilch H, Lehr HA, Hengstler JG, Kölbl H and Gehrmann M: The
humoral immune system has a key prognostic impact in node-negative
breast cancer. Cancer Res. 68:5405–5413. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Al-Shibli KI, Donnem T, Al-Saad S, Persson
M, Bremnes RM and Busund LT: Prognostic effect of epithelial and
stromal lymphocyte infiltration in non-small cell lung cancer. Clin
Cancer Res. 14:5220–5227. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Nielsen JS, Sahota RA, Milne K, Kost SE,
Nesslinger NJ, Watson PH and Nelson BH: CD20+
tumor-infiltrating lymphocytes have an atypical CD27−
memory phenotype and together with CD8+ T cells promote
favorable prognosis in ovarian cancer. Clin Cancer Res.
18:3281–3292. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Shi JY, Gao Q, Wang ZC, Jian Zhou, Wang
XY, Min ZH, Shi YH, Shi GM, Ding ZB, Ke AW, et al:
Margin-infiltrating CD20(+) B cells display an atypical memory
phenotype and correlate with favorable prognosis in hepatocellular
carcinoma. Clin Cancer Res. 19:5994–6005. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Sakimura C, Tanaka H, Okuno T, Hiramatsu
S, Muguruma K, Hirakawa K, Wanibuchi H and Ohira M: B cells in
tertiary lymphoid structures are associated with favorable
prognosis in gastric cancer. J Surg Res. 215:74–82. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Neyt K, Perros F, GeurtsvanKessel CH,
Hammad H and Lambrecht BN: Tertiary lymphoid organs in infection
and autoimmunity. Trends Immunol. 33:297–305. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Dieu-Nosjean MC, Goc J, Giraldo NA,
Sautès-Fridman C and Fridman WH: Tertiary lymphoid structures in
cancer and beyond. Trends Immunol. 35:571–580. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Winter S, Loddenkemper C, Aebischer A,
Räbel K, Hoffmann K, Meyer TF, Lipp M and Höpken UE: The chemokine
receptor CXCR5 is pivotal for ectopic mucosa-associated lymphoid
tissue neogenesis in chronic Helicobacter pylori-induced
inflammation. J Mol Med (Berl). 88:1169–1180. 2010. View Article : Google Scholar
|
|
12
|
Nasr IW, Reel M, Oberbarnscheidt MH,
Mounzer RH, Baddoura FK, Ruddle NH and Lakkis FG: Tertiary lymphoid
tissues generate effector and memory T cells that lead to allograft
rejection. Am J Transplant. 7:1071–1079. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Dieu-Nosjean MC, Giraldo NA, Kaplon H,
Germain C, Fridman WH and Sautès-Fridman C: Tertiary lymphoid
structures, drivers of the anti-tumor responses in human cancers.
Immunol Rev. 271:260–275. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Germain C, Gnjatic S, Tamzalit F,
Knockaert S, Remark R, Goc J, Lepelley A, Becht E, Katsahian S,
Bizouard G, et al: Presence of B cells in tertiary lymphoid
structures is associated with a protective immunity in patients
with lung cancer. Am J Respir Crit Care Med. 189:832–844. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Hennequin A, Derangère V, Boidot R, Apetoh
L, Vincent J, Orry D, Fraisse J, Causeret S, Martin F, Arnould L,
et al: Tumor infiltration by Tbet+ effector T cells and
CD20+ B cells is associated with survival in gastric
cancer patients. Oncoimmunology. 5:e10545982015. View Article : Google Scholar
|
|
16
|
Schweiger T, Berghoff AS, Glogner C,
Glueck O, Rajky O, Traxler D, Birner P, Preusser M, Klepetko W and
Hoetzenecker K: Tumor-infiltrating lymphocyte subsets and tertiary
lymphoid structures in pulmonary metastases from colorectal cancer.
Clin Exp Metastasis. 33:727–739. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Figenschau SL, Fismen S, Fenton KA, Fenton
C and Mortensen ES: Tertiary lymphoid structures are associated
with higher tumor grade in primary operable breast cancer patients.
BMC Cancer. 15:1012015. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Wirsing AM, Rikardsen OG, Steigen SE,
Uhlin-Hansen L and Hadler-Olsen E: Characterisation and prognostic
value of tertiary lymphoid structures in oral squamous cell
carcinoma. BMC Clin Pathol. 14:382014. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Sobin LH, Gospodarowicz MK and Wittekind
C: TNM Classification of Malignant Tumours International Union
Against Cancer. Wiley-Blackwell; West Sussex: pp. 3362010
|
|
20
|
Japanese Gastric Cancer Association:
Japanese classification of gastric carcinoma: 3rd English edition.
Gastric Cancer. 14:101–112. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Tan YS and Lei YL: Isolation of
tumor-infiltrating lymphocytes by Ficoll-Paque density gradient
centrifugation. Methods Mol Biol. 1960:93–99. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Pascual V, Liu YJ, Magalski A, de
Bouteiller O, Banchereau J and Capra JD: Analysis of somatic
mutation in five B cell subsets of human tonsil. J Exp Med.
180:329–339. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Welschof M, Terness P, Kolbinger F, Zewe
M, Dübel S, Dörsam H, Hain C, Finger M, Jung M, Moldenhauer G, et
al: Amino acid sequence based PCR primers for amplification of
rearranged human heavy and light chain immunoglobulin variable
region genes. J Immunol Methods. 179:203–214. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar
|
|
25
|
Pimenta EM and Barnes BJ: Role of tertiary
lymphoid structures (TLS) in anti-tumor immunity: Potential
tumor-induced cytokines/chemokines that regulate TLS formation in
epithelial-derived cancers. Cancers (Basel). 6:969–997. 2014.
View Article : Google Scholar
|
|
26
|
Carragher DM, Rangel-Moreno J and Randall
TD: Ectopic lymphoid tissues and local immunity. Semin Immunol.
20:26–42. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Carney JA: Gastric mucosal lymphoid
follicles: Histology, distribution, frequency, and etiologic
features. Am J Surg Pathol. 34:1019–1024. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Klein U and Dalla-Favera R: Germinal
centres: Role in B-cell physiology and malignancy. Nat Rev Immunol.
8:22–33. 2008. View Article : Google Scholar
|
|
29
|
Inoue T, Moran I, Shinnakasu R, Phan TG
and Kurosaki T: Generation of memory B cells and their
reactivation. Immunol Rev. 283:138–149. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Lin L, Hu X, Zhang H and Hu H: Tertiary
lymphoid organs in cancer immunology: Mechanisms and the new
strategy for immunotherapy. Front Immunol. 10:13982019. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Kroeger DR, Milne K and Nelson BH:
Tumor-infiltrating plasma cells are associated with tertiary
lymphoid structures, cytolytic T-cell responses, and superior
prognosis in ovarian cancer. Clin Cancer Res. 22:3005–3015. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Lohr M, Edlund K, Botling J, Hammad S,
Hellwig B, Othman A, Berglund A, Lambe M, Holmberg L, Ekman S, et
al: The prognostic relevance of tumour-infiltrating plasma cells
and immunoglobulin kappa C indicates an important role of the
humoral immune response in non-small cell lung cancer. Cancer Lett.
333:222–228. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Berntsson J, Nodin B, Eberhard J, Micke P
and Jirström K: Prognostic impact of tumour-infiltrating B cells
and plasma cells in colorectal cancer. Int J Cancer. 139:1129–1139.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Mohammed ZM, Going JJ, Edwards J,
Elsberger B and McMillan DC: The relationship between lymphocyte
subsets and clinico-pathological determinants of survival in
patients with primary operable invasive ductal breast cancer. Br J
Cancer. 109:1676–1684. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Borst J, Hendriks J and Xiao Y: CD27 and
CD70 in T cell and B cell activation. Curr Opin Immunol.
17:275–281. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Deola S, Panelli MC, Maric D, Selleri S,
Dmitrieva NI, Voss CY, Klein H, Stroncek D, Wang E and Marincola
FM: Helper B cells promote cytotoxic T cell survival and
proliferation independently of antigen presentation through
CD27/CD70 interactions. J Immunol. 180:1362–1372. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Arens R, Schepers K, Nolte MA, van
Oosterwijk MF, van Lier RA, Schumacher TN and van Oers MH: Tumor
rejection induced by CD70-mediated quantitative and qualitative
effects on effector CD8+ T cell formation. J Exp Med.
199:1595–1605. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
van de Ven K and Borst J: Targeting the
T-cell co-stimulatory CD27/CD70 pathway in cancer immunotherapy:
Rationale and potential. Immunotherapy. 7:655–667. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Germain C, Gnjatic S and Dieu-Nosjean MC:
Tertiary lymphoid structure-associated B cells are key players in
anti-tumor immunity. Front Immunol. 6:672015. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Sautès-Fridman C, Lawand M, Giraldo NA,
Kaplon H, Germain C, Fridman WH and Dieu-Nosjean MC: Tertiary
lymphoid structures in cancers: Prognostic value, regulation, and
manipulation for therapeutic intervention. Front Immunol.
7:4072016. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Mebius RE: Organogenesis of lymphoid
tissues. Nat Rev Immunol. 3:292–303. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Sáez de Guinoa J, Barrio L, Mellado M and
Carrasco YR: CXCL13/CXCR5 signaling enhances BCR-triggered B-cell
activation by shaping cell dynamics. Blood. 118:1560–1569. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Lundy SK: Killer B lymphocytes: The
evidence and the potential. Inflamm Res. 58:345–357. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Hagn M, Schwesinger E, Ebel V, Sontheimer
K, Maier J, Beyer T, Syrovets T, Laumonnier Y, Fabricius D, Simmet
T, et al: Human B cells secrete granzyme B when recognizing viral
antigens in the context of the acute phase cytokine IL-21. J
Immunol. 183:1838–1845. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Hagn M, Sontheimer K, Dahlke K,
Brueggemann S, Kaltenmeier C, Beyer T, Hofmann S, Lunov O, Barth
TF, Fabricius D, et al: Human B cells differentiate into granzyme
B-secreting cytotoxic B lymphocytes upon incomplete T-cell help.
Immunol Cell Biol. 90:457–467. 2012. View Article : Google Scholar
|
|
46
|
Crew KD and Neugut AI: Epidemiology of
gastric cancer. World J Gastroenterol. 12:354–362. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Maoz A, Dennis M and Greenson JK: The
Crohn's-like lymphoid reaction to colorectal cancer-tertiary
lymphoid structures with immunologic and potentially therapeutic
relevance in colorectal cancer. Front Immunol. 10:18842019.
View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Hendriks J, Xiao Y, Rossen JW, van der
Sluijs KF, Sugamura K, Ishii N, Borst J, et al: During viral
infection of the respiratory tract, CD27, 4-1BB, and OX40
collectively determine formation of CD8+ memory T cells
and their capacity for secondary expansion. J Immunol.
175:1665–1676. 2005. View Article : Google Scholar : PubMed/NCBI
|
